A Long, Unnerving Road: Malpractice Claims Involving the Surgical Management of Thyroid and Parathyroid Disease.


Journal

World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052

Informations de publication

Date de publication:
11 2019
Historique:
pubmed: 7 8 2019
medline: 2 7 2020
entrez: 7 8 2019
Statut: ppublish

Résumé

Given their profound emotional, physical, and financial toll on patients and surgeons, we studied the characteristics, costs, and contributing factors of thyroid and parathyroid surgical malpractice claims. Using the Controlled Risk Insurance Company Strategies' Comparative Benchmarking System database, representing ~30% of all US paid and unpaid malpractice claims, 5384 claims filed against general surgeons and otolaryngologists from 1995-2015 were reviewed to isolate claims involving the surgical management of thyroid and parathyroid disease. These claims were studied, and multivariable regression analysis was performed to identify factors associated with plaintiff payout. One hundred twenty-eight thyroid and parathyroid surgical malpractice claims were isolated. The median time from alleged harm event to closure of a malpractice case was 39 months. The most common associated complications were bilateral recurrent laryngeal nerve (RLN) injury (n = 23) and hematoma (n = 18). Complications led to death in 18 cases. Patient payout occurred in 33% of claims (n = 42), and the median cost per claim was $277,913 (IQR $87,343-$783,663). On multivariable analysis, bilateral RLN injury was predictive of patient payout (OR 3.58, p = 0.03), while procedure, death, and surgeon specialty were not. Though rare, malpractice claims related to thyroid and parathyroid surgery are costly, time-consuming, and reveal opportunities for early surgeon-patient resolution after poor outcomes.

Sections du résumé

BACKGROUND
Given their profound emotional, physical, and financial toll on patients and surgeons, we studied the characteristics, costs, and contributing factors of thyroid and parathyroid surgical malpractice claims.
METHODS
Using the Controlled Risk Insurance Company Strategies' Comparative Benchmarking System database, representing ~30% of all US paid and unpaid malpractice claims, 5384 claims filed against general surgeons and otolaryngologists from 1995-2015 were reviewed to isolate claims involving the surgical management of thyroid and parathyroid disease. These claims were studied, and multivariable regression analysis was performed to identify factors associated with plaintiff payout.
RESULTS
One hundred twenty-eight thyroid and parathyroid surgical malpractice claims were isolated. The median time from alleged harm event to closure of a malpractice case was 39 months. The most common associated complications were bilateral recurrent laryngeal nerve (RLN) injury (n = 23) and hematoma (n = 18). Complications led to death in 18 cases. Patient payout occurred in 33% of claims (n = 42), and the median cost per claim was $277,913 (IQR $87,343-$783,663). On multivariable analysis, bilateral RLN injury was predictive of patient payout (OR 3.58, p = 0.03), while procedure, death, and surgeon specialty were not.
CONCLUSION
Though rare, malpractice claims related to thyroid and parathyroid surgery are costly, time-consuming, and reveal opportunities for early surgeon-patient resolution after poor outcomes.

Identifiants

pubmed: 31384995
doi: 10.1007/s00268-019-05102-y
pii: 10.1007/s00268-019-05102-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2850-2855

Références

N Engl J Med. 2006 May 11;354(19):2024-33
pubmed: 16687715
PLoS One. 2016 Aug 16;11(8):e0161192
pubmed: 27529699
JAMA Otolaryngol Head Neck Surg. 2016 Jan;142(1):32-9
pubmed: 26561736
Ann Surg. 2019 May;269(5):785-791
pubmed: 30601246
Langenbecks Arch Surg. 2017 Jun;402(4):663-673
pubmed: 28378238
Health Care Manag (Frederick). 2011 Jan-Mar;30(1):55-65
pubmed: 21248550
J Am Coll Surg. 2011 Nov;213(5):657-67
pubmed: 21890381
Br J Surg. 2017 Oct;104(11):1523-1531
pubmed: 28707698
Surgery. 2010 Oct;148(4):718-22; discussion 722-3
pubmed: 20709343
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
Surgery. 1993 Dec;114(6):1167-73; discussion 1173-4
pubmed: 8256224
Surgery. 2013 Dec;154(6):1420-6; discussion 1426-7
pubmed: 24094448

Auteurs

Rajshri M Gartland (RM)

Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. rgartland@mgh.harvard.edu.
Lawrence Center for Quality and Safety, Massachusetts General Hospital, Massachusetts General Physicians Organization, Boston, MA, USA. rgartland@mgh.harvard.edu.

Jordan P Bloom (JP)

Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Sareh Parangi (S)

Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Richard Hodin (R)

Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Courtney DeRoo (C)

CRICO Risk Management Foundation, Boston, MA, USA.

Antonia E Stephen (AE)

Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Vinod Narra (V)

Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Carrie C Lubitz (CC)

Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Elizabeth Mort (E)

Lawrence Center for Quality and Safety, Massachusetts General Hospital, Massachusetts General Physicians Organization, Boston, MA, USA.
Division of General Internal Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH